Treatment for Type 2 Diabetes

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Type 2 Diabetes
Eligibility
30 - 65
All Sexes
What conditions do you have?
Select

Study Summary

This trial looks at how exercise affects insulin resistance in people with Type 2 Diabetes.

Eligible Conditions
  • Type 2 Diabetes

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: 24 hours

24 hours
Individual steps of muscle glucose uptake (post-exercise)
Individual steps of muscle glucose uptake (pre-exercise)

Trial Safety

Safety Progress

1 of 3

Trial Design

0 Treatment Group

12 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 24 hours

Who is running the clinical trial?

Translational Research Institute for Metabolism and Diabetes, FloridaLead Sponsor
40 Previous Clinical Trials
3,528 Total Patients Enrolled
AdventHealth Translational Research InstituteLead Sponsor
44 Previous Clinical Trials
19,995 Total Patients Enrolled
Bret Goodpaster, PhDPrincipal InvestigatorScientific Director | Senior Investigator
4 Previous Clinical Trials
448 Total Patients Enrolled

Eligibility Criteria

Age 30 - 65 · All Participants · 7 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
or a glycated hemoglobin ≥6.5% Type 2 diabetes is a chronic condition that is determined by either self-report or a fasting glucose level of more than 126 mg/dl or a glycated hemoglobin level of 6.5 percent or higher.
The subject has maintained a stable weight within a 2 kg range for the past 3 months.
, the study population was large (N = 237), and the intervention was well described
You have a body mass index (BMI) between 25 and 45 kg/m2.
or insufficiently active (less than 7 days per week of any activity) adults (>18 years) are at increased risk for adverse health outcomes